We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$11.4B
AUM Growth
+$1.09B
Cap. Flow
+$423M
Cap. Flow %
3.71%
Top 10 Hldgs %
44.94%
Holding
631
New
66
Increased
163
Reduced
192
Closed
151

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$153M
2
V icon
Visa
V
+$56.4M
3
EWJ icon
iShares MSCI Japan ETF
EWJ
+$29.9M
4
CI icon
Cigna
CI
+$20.5M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$17.2M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$238M
2
TSLA icon
Tesla
TSLA
+$121M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14.7M
4
WOLF icon
Wolfspeed
WOLF
+$11.7M
5
AMD icon
Advanced Micro Devices
AMD
+$11.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.97%
2 Healthcare 17.61%
3 Consumer Staples 11.48%
4 Technology 11.09%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
101
Pfizer
PFE
$154B
$11.2M 0.1%
304,772
+75,789
+33% +$2.95M
BRK.B icon
102
Berkshire Hathaway Class B
BRK.B
$1.13T
$11.2M 0.1%
32,769
+13,777
+73% +$4.5M
LOW icon
103
Lowe's Companies
LOW
$123B
$11.2M 0.1%
49,422
-893
-2% -$186K
LRCX icon
104
Lam Research
LRCX
$383B
$10.6M 0.09%
165,140
+4,030
+3% +$227K
NEM icon
105
Newmont
NEM
$124B
$10.6M 0.09%
248,650
-16,628
-6% -$755K
AZN icon
106
AstraZeneca
AZN
$251B
$10.4M 0.09%
72,636
-3,278
-4% -$482K
EVGO icon
107
EVgo
EVGO
$500M
$9.96M 0.09%
2,490,000
+191,400
+8% +$977K
VRTX icon
108
Vertex Pharmaceuticals
VRTX
$133B
$9.9M 0.09%
28,122
+1,215
+5% +$409K
SOPH icon
109
SOPHiA GENETICS
SOPH
$643M
$9.8M 0.09%
2,187,340
– –
STLA icon
110
Stellantis
STLA
$21B
$9.79M 0.09%
557,633
-48,189
-8% -$808K
APLS
111
DELISTED
Apellis Pharmaceuticals
APLS
$9.76M 0.09%
107,135
-31,467
-23% -$2.72M
AMP icon
112
Ameriprise Financial
AMP
$49.2B
$9.61M 0.08%
28,924
+8,316
+40% +$2.56M
AMAT icon
113
Applied Materials
AMAT
$415B
$9.55M 0.08%
66,100
+5,617
+9% +$703K
SYK icon
114
Stryker
SYK
$133B
$9.47M 0.08%
31,034
-8,263
-21% -$2.39M
CSCO icon
115
Cisco
CSCO
$483B
$9.41M 0.08%
181,818
+66,579
+58% +$3.27M
ROK icon
116
Rockwell Automation
ROK
$48.3B
$9.28M 0.08%
28,170
-5,223
-16% -$1.51M
ICLR icon
117
Icon
ICLR
$12.8B
$9.22M 0.08%
36,865
+14,227
+63% +$3.02M
AFL icon
118
Aflac
AFL
$61.1B
$9.19M 0.08%
131,700
+112,220
+576% +$7.51M
MU icon
119
Micron Technology
MU
$972B
$9.12M 0.08%
144,551
-14,654
-9% -$942K
HCA icon
120
HCA Healthcare
HCA
$89.6B
$8.97M 0.08%
29,565
-7,359
-20% -$2.05M
HDB icon
121
HDFC Bank
HDB
$120B
$8.53M 0.07%
244,642
-1,830
-0.7% -$61.7K
ACN icon
122
Accenture
ACN
$109B
$8.49M 0.07%
27,505
+3,092
+13% +$898K
IBM icon
123
IBM
IBM
$223B
$8.09M 0.07%
60,443
+304
+0.5% +$39.2K
EXPD icon
124
Expeditors International
EXPD
$23.3B
$7.95M 0.07%
65,643
-21,306
-25% -$2.42M
ADM icon
125
Archer Daniels Midland
ADM
$38.8B
$7.77M 0.07%
102,785
+18,074
+21% +$1.37M
3 4
5
6 7

Similar funds

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCMG
Clark Capital Management Group Philadelphia, Pennsylvania $16.2B AUM 29.8% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Banque Pictet & Cie's Q2 2023 Portfolio in Review

As of Q2 2023, Banque Pictet & Cie held 631 positions worth $11.4B, up 11% from $10.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Banque Pictet & Cie deployed $423M of net new capital in Q2 2023, opening 66 new positions and adding to 163 existing holdings. Its largest new stake was MoonLake Immunotherapeutics: 640,000 shares worth $32.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $238M trimmed.

  • Banque Pictet & Cie's largest Q2 2023 buy was MoonLake Immunotherapeutics: 640,000 shares worth $32.6M.
  • Banque Pictet & Cie added most to Estee Lauder in Q2 2023, an estimated $153M increase.
  • Banque Pictet & Cie's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $238M.
  • Banque Pictet & Cie fully exited Wolfspeed in Q2 2023, selling an estimated $11.7M.
  • Banque Pictet & Cie's ten largest holdings make up 45% of its $11.4B portfolio in Q2 2023.
  • Banque Pictet & Cie opened 66 new positions and closed 151 in Q2 2023.
  • Banque Pictet & Cie's portfolio value rose 11% quarter-over-quarter to $11.4B.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.